Journal of Clinical Endocrinology & Metabolism, Vol 81, 2080-2088, Copyright © 1996 by Endocrine Society

ARTICLES

Homologous in vitro bioassay for follicle-stimulating hormone (FSH) reveals increased FSH biological signal during the mid- to late luteal phase of the human menstrual cycle

S Christin-Maitre, AE Taylor, RH Khoury, JE Hall, KA Martin, PC Smith, C Albanese, JL Jameson, WF Crowley Jr and PM Sluss
National Center for Infertility Research, Department of Medicine, Massachusetts General Hospital, Boston 02114, USA.

Monitoring of the secretory dynamics of FSH during the human menstrual cycle has demonstrated conflicting results between the amounts of FSH measured by dimer-specific immunoassays and previous heterologous in vitro bioassays. These differences suggest somewhat different models of the steroidal and nonsteroidal regulation of FSH secretion and its control of folliculogenesis in the human. We have developed a homologous in vitro bioassay, using the recombinant human FSH receptor cotransfected into Chinese hamster ovary cells with a cAMP-responsive luciferase reporter gene, that overcomes many of the theoretic shortfalls of previous assays and allows reevaluation of the changes in bioactive FSH across the menstrual cycle. Bioactive FSH levels measured across 12 menstrual cycles in 11 normal women ranged from 4-40 IU/L. FSH bioactivity was constant during the menstrual cycle, with elevations noted only during the mid- to late luteal phase. Bioactive FSH levels were similar to immunoactive FSH levels across the cycle as indicated by a ratio of bioactive to immunoreactive FSH (FSH B/I) of 1.10 +/- 0.04 across the follicular and early luteal phases. However, during the mid- to late luteal phase, the mean FSH B/I rose to 1.65 +/- 0.07, which significantly exceeded that during the rest of the cycle (P < 0.001). This change in FSH B/I occurs at a critical time during folliculogenesis when the next cohort of follicles is being recruited and appears to be secondary to a decrease in immunoreactive FSH unaccompanied by a similar decrease in in vitro bioactivity. There was good agreement between immunoassay and bioassay results on the day of the midcycle gonadotropin surge (FSH B/I = 1.07 +/- 0.14), which was not different from that in the follicular phase (days -17 to -2; FSH B/I = 1.06 +/- 0.05) or the FSH B/I measured in postmenopausal women (0.93 +/- 0.2). These observations using a novel homologous human FSH in vitro bioassay indicate that bioactive FSH levels are not declining during the time of active corpus luteum formation and secretory activity. Thus, there is a previously undetected increased biologic signal during the mid- to late luteal phase, suggesting that the influence of elevated FSH on the cohort of developing follicles (including the subsequent dominant follicle) begins earlier during the luteal-follicular transition than previously predicted by FSH immunoreactivity.

This article has been cited by other articles:

				I. E. Messinis Ovarian feedback, mechanism of action and possible clinical implications Hum. Reprod. Update, September 1, 2006; 12(5): 557 - 571. [Abstract] [Full Text] [PDF]

				L. C. Layman, A. L. A. Porto, J. Xie, L. A. C. R. da Motta, L. D. C. da Motta, W. Weiser, and P. M. Sluss FSH{beta} Gene Mutations in a Female with Partial Breast Development and a Male Sibling with Normal Puberty and Azoospermia J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3702 - 3707. [Abstract] [Full Text] [PDF]

				R. B. Barnes, A. B. Namnoum, R. L. Rosenfield, and L. C. Layman The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: Clinical studies in a patient with isolated FSH deficiency and multicystic ovaries: Case report Hum. Reprod., January 1, 2002; 17(1): 88 - 91. [Abstract] [Full Text] [PDF]

				T. Zarinan, A. Olivares, D. Soderlund, J.P. Mendez, and A. Ulloa-Aguirre Changes in the biological:immunological ratio of basal and GnRH-releasable FSH during the follicular, pre-ovulatory and luteal phases of the human menstrual cycle Hum. Reprod., August 1, 2001; 16(8): 1611 - 1618. [Abstract] [Full Text] [PDF]

				A. Ulloa-Aguirre, C. Timossi, and J.P. Mendez Is there any physiological role for gonadotrophin oligosaccharide heterogeneity in humans?: I. Gondatrophins are synthesized and released in multiple molecular forms. A matter of fact Hum. Reprod., April 1, 2001; 16(4): 599 - 604. [Abstract] [Full Text] [PDF]

				A.-M. Suikkari, M. Tulppala, T. Tuuri, O. Hovatta, and F. Barnes Luteal phase start of low-dose FSH priming of follicles results in an efficient recovery, maturation and fertilization of immature human oocytes Hum. Reprod., April 1, 2000; 15(4): 747 - 751. [Abstract] [Full Text] [PDF]

				M. P. Rose, R. E. Gaines Das, and A. H. Balen Definition and Measurement of Follicle Stimulating Hormone Endocr. Rev., February 1, 2000; 21(1): 5 - 22. [Abstract] [Full Text]

				H.M. Buckler, W.R. Robertson, A. Anderson, M. Vickers, and A. Lambert Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon) Hum. Reprod., December 1, 1999; 14(12): 2969 - 2973. [Abstract] [Full Text] [PDF]

				M. J. De Souza, B. E. Miller, A. B. Loucks, A. A. Luciano, L. S. Pescatello, C. G. Campbell, and B. L. Lasley High Frequency of Luteal Phase Deficiency and Anovulation in Recreational Women Runners: Blunted Elevation in Follicle-Stimulating Hormone Observed during Luteal-Follicular Transition J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4220 - 4232. [Abstract] [Full Text]

				S. Christin-Maitre, C. Rongières-Bertrand, M.-L. Kottler, N. Lahlou, R. Frydman, P. Touraine, and P. Bouchard A Spontaneous and Severe Hyperstimulation of the Ovaries Revealing a Gonadotroph Adenoma J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3450 - 3453. [Abstract] [Full Text]

				U.A. Vitt,, H.J. Kloosterboer,, U.M. Rose,, J.W.M. Mulders,, P.S. Kiesel,, S. Bete,, and P.L. Nayudu Isoforms of Human Recombinant Follicle-Stimulating Hormone: Comparison of Effects on Murine Follicle Development In Vitro Biol Reprod, October 1, 1998; 59(4): 854 - 861. [Abstract] [Full Text]

				M. Simoni, J. Gromoll, and E. Nieschlag The Follicle-Stimulating Hormone Receptor: Biochemistry, Molecular Biology, Physiology, and Pathophysiology Endocr. Rev., December 1, 1997; 18(6): 739 - 773. [Abstract] [Full Text]

				L. C. Layman, E.-J. Lee, D. B. Peak, A. B. Namnoum, K. V. Vu, B. L. van Lingen, M. R. Gray, P. G. McDonough, R. H. Reindollar, and J. L. Jameson Delayed Puberty and Hypogonadism Caused by Mutations in the Follicle-Stimulating Hormone {beta}-Subunit Gene N. Engl. J. Med., August 28, 1997; 337(9): 607 - 611. [Full Text] [PDF]

				G. Watanabe, P. Pena, C. Albanese, L. D. Wilsbacher, J. B. Young, and R. G. Pestell Adrenocorticotropin Induction of Stress-activated Protein Kinase in the Adrenal Cortex in Vivo J. Biol. Chem., August 8, 1997; 272(32): 20063 - 20069. [Abstract] [Full Text] [PDF]

				I. Schipper, F. F. G. Rommerts, P. M. ten Hacken, and B. C. J. M. Fauser Low Levels of Follicle-Stimulating Hormone Receptor-Activation Inhibitors in Serum and Follicular Fluid from Normal Controls and Anovulatory Patients with or without Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1325 - 1331. [Abstract] [Full Text] [PDF]